| Disease | prostate cancer |
| Symptom | C0025517|metabolic disorder |
| Sentences | 2 |
| PubMedID- 19760629 | Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (adt): impact of adt on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis. |
| PubMedID- 23098789 | So far no consensus guidelines have been published regarding the screening and treatment of metabolic disorders in men with prostate cancer. |
Page: 1